433 related articles for article (PubMed ID: 10528707)
1. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
Hörl WH; de Alvaro F; Williams PF
Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
[TBL] [Abstract][Full Text] [Related]
2. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
De Vecchi AF; Dratwa M; Wiedemann ME
Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
[TBL] [Abstract][Full Text] [Related]
3. End-stage renal disease in India and Pakistan: burden of disease and management issues.
Sakhuja V; Sud K
Kidney Int Suppl; 2003 Feb; (83):S115-8. PubMed ID: 12864888
[TBL] [Abstract][Full Text] [Related]
4. Dialysis Care and Dialysis Funding in Asia.
Tang SCW; Yu X; Chen HC; Kashihara N; Park HC; Liew A; Goh BL; Nazareth MGC; Bunnag S; Tan J; Lun V; Lydia A; Sharma SK; Hoque E; Togtokh A; Ghnaimet M; Jha V
Am J Kidney Dis; 2020 May; 75(5):772-781. PubMed ID: 31699518
[TBL] [Abstract][Full Text] [Related]
5. End-stage renal care in developing countries: the India experience.
Jha V
Ren Fail; 2004 May; 26(3):201-8. PubMed ID: 15354966
[TBL] [Abstract][Full Text] [Related]
6. The dilemmas of patient treatment for end-stage renal disease.
Schmidt RW; Blumenkrantz M; Wiegmann TB
Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
[TBL] [Abstract][Full Text] [Related]
7. Current status of end-stage renal disease care in South Asia.
Jha V
Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for insulin-dependent diabetics with ESRD: a cost-effectiveness decision analysis model.
Douzdjian V; Ferrara D; Silvestri G
Am J Kidney Dis; 1998 May; 31(5):794-802. PubMed ID: 9590189
[TBL] [Abstract][Full Text] [Related]
10. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
Hidai H
Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
[TBL] [Abstract][Full Text] [Related]
11. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
[TBL] [Abstract][Full Text] [Related]
12. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
13. Healthcare systems--an international review: an overview.
Lameire N; Joffe P; Wiedemann M
Nephrol Dial Transplant; 1999; 14 Suppl 6():3-9. PubMed ID: 10528706
[TBL] [Abstract][Full Text] [Related]
14. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
15. [Cost-effectiveness analysis of treatment for end-stage renal disease].
Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.
Sandoz MS; Ess SM; Keusch GW; Schwenkglenks M; Szucs TD
Swiss Med Wkly; 2004 Aug; 134(31-32):448-58. PubMed ID: 15389348
[TBL] [Abstract][Full Text] [Related]
17. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
18. Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.
Van Biesen W; Lameire N; Peeters P; Vanholder R
Int J Health Care Finance Econ; 2007 Sep; 7(2-3):133-48. PubMed ID: 17638074
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
20. The organization and financing of kidney dialysis and transplant care in the United States of America.
Hirth RA
Int J Health Care Finance Econ; 2007 Dec; 7(4):301-18. PubMed ID: 17602296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]